To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

COA-ACO2018: Ketotifen fumarate vs. placebo for joint contracture after elbow fracture/dislocation

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
July 2018

COA-ACO2018: Ketotifen fumarate vs. placebo for joint contracture after elbow fracture/dislocation

Vol: 7| Issue: 7| Number:4| ISSN#: 2564-2537
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Randomized, Placebo-Controlled Clinical Trial Evaluating Ketotifen Fumarate in Reduction of Posttraumatic Elbow Joint Contracture

Contributing Authors:
PS Schneider

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CONFERENCE ACE REPORTS

This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.

Synopsis

152 patients with an elbow dislocation, distal humerus fracture or proximal radius fracture, with or without concomitant ulna fracture, were randomized to either oral ketotifen fumarate or lactose placebo. Patients were assessed at 12 weeks post-injury for elbow range of motion in flexion-extension, the Disabilities of the Arm Shoulder, and Hand (DASH) questionnaire, incidence of complications, an...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue